InsiderClue
← All stocks

Tango Therapeutics, Inc.

TNGX Net selling
CIK 0001819133 #1540 in the set updated 17 Sep 2026
Bought (120 mo)
$18.34M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$94.65M
$1.03M on a plan · $5.10M straight out of an exercise
Sold at will
$88.51M
66 of 81 sales
Net
−$76.31M
−$70.17M against sales at will

By person

21 insiders · 94 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Third Rock Ventures IV, L.P. entity
10% owner
—
$51.85M (24)
−$51.85M
13,386,574
7.94%
$299.42M
−30.9%
Boxer Capital Management, LLC entity
See remarks
—
$20.12M (4)
−$20.12M
10,301,284
6.11%
$230.41M
−30.8%
Boxer Capital, LLC entity
See remarks
$12.93M (10)
$2.24M (2)
+$10.69M
8,892,166
5.27%
$198.89M
+27.5%
EcoR1 Capital, LLC entity
10% owner
—
$8.44M (3)
−$8.44M
10,630,736
6.30%
$237.78M
−20.3%
Crystal Adam
President, R&D
—
$6.54M (21) scheduled
−$6.54M
115,743
0.0686%
$2.59M
+989.0%
BCTG Holdings, LLC entity
10% owner
$5.34M (1)
$30.00 (2)
+$5.33M
4,488,450
2.66%
$100.39M
+13.3%
MVA Investors, LLC entity
See remarks
—
$4.62M (8)
−$4.62M
592,317
0.3513%
$13.25M
−49.7%
Weber Barbara
Director, Executive Chair
—
$547.06K (6)
−$547.06K
1,629,254
0.9663%
$36.44M
+19.1%
Beckman Daniella
Chief Financial Officer
—
$198.71K (6)
−$198.71K
184,297
0.1093%
$4.12M
+188.6%
Rothenberg Mace
Director
$74.00K (2)
—
+$74.00K
41,500
0.0246%
$928.23K
—
Barry Douglas
General Counsel
—
$51.32K (4)
−$51.32K
66,014
0.0392%
$1.48M
—
Calhoun Lesley Ann
Director
—
$36.04K (1) scheduled
−$36.04K
16,500
0.0098%
$369.06K
—
Peters Malte
President & CEO
—
—
—
367,500
0.2180%
$8.22M
—
Huang Alan
Chief Scientific Officer
—
—
—
167,584
0.0994%
$3.75M
+23.3%
Gall Matthew
Chief Financial Officer
—
—
—
40,000
0.0237%
$894.68K
—
Ketchum John B
Director
—
—
—
24,937
0.0148%
$557.77K
—
Lee Sung
Director
—
—
—
22,870
0.0136%
$511.53K
—
Borisy Alexis
Director
—
—
—
17,500
0.0104%
$391.42K
—
Azelby Robert
Director
—
—
—
5,740
0.0034%
$128.39K
—
Davis Aaron I.
See remarks.
—
—
—
5,000
0.0030%
$111.84K
—
Huber Reid M
Director
—
—
—
5,000
0.0030%
$111.84K
—

Individual transactions

12
Insider
Date
Role
Action
Shares
Price
Amount
Crystal Adam
1 Sep 2026
President, R&D
Sold after exercise
27,000
$22.37
$603.91K
Crystal Adam
3 Aug 2026
President, R&D
Sold after exercise
21,733
$27.35
$594.42K
Crystal Adam
3 Aug 2026
President, R&D
Sold after exercise
5,267
$26.79
$141.10K
Crystal Adam
1 Jul 2026
President, R&D
Sold after exercise
7,371
$30.25
$222.95K
Crystal Adam
1 Jul 2026
President, R&D
Sold after exercise
19,629
$29.34
$575.96K
Crystal Adam
1 Jun 2026
President, R&D
Sold after exercise
20,860
$23.06
$480.94K
Crystal Adam
1 Jun 2026
President, R&D
Sold after exercise
6,140
$22.25
$136.63K
Crystal Adam
1 May 2026
President, R&D
Sold after exercise
1,100
$22.00
$24.20K
Crystal Adam
1 May 2026
President, R&D
Sold after exercise
25,900
$21.19
$548.90K
Crystal Adam
15 Apr 2026
President, R&D
Sold after exercise
38,460
$25.00
$961.50K
Crystal Adam
1 Apr 2026
President, R&D
Sold after exercise
27,000
$21.20
$572.48K
Crystal Adam
25 Mar 2026
President, R&D
Sold after exercise
12,000
$20.11
$241.32K
Show all 94 transactions →

What was left out

Form 4 filings counted 111
Amendments (4/A) skipped 2
Filings about a different issuer 1
Unreadable filings 0
Joint filings 29
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 12
Sales at will 66
Transactions with no price 0
Shares from compensation/vesting 1,540,962
Sales filed before the plan box existed 2
History held since 10 Sep 2020